Trends in Biomanufacturing
Information
Innovative biotherapeutics and novel technologies are currently being developed and commercialised at record levels, providing practical treatments for patients with cancers and autoimmune diseases across the world. In 2019 the FDA approved 48 novel drugs, several of which represent advanced, first-in-class therapies. It comes as no surprise then to hear that venture capital funding into US-based biotech firms was $3.5 billion+ for each of the last eight quarters leading into 2020, according to Pitchbook data.
Today, in the fight against the novel COVID-19 virus all eyes are on the global scientific community who have come together to work on and produce various treatments and vaccines at record speed, and we are reminded just how important scientific innovation is.
Join us for the webinar Trends in Biomanufacturing and hear from industry experts to discuss the following:
- Product pipeline - what is the latest overview?
- Which products post key manufacturing challenges?
- Securing and sustaining the right talent pool to support growthInnovation in manufacturing techniques - bioanalytical capabilities, cell line development, aseptic manufacturing, downstream/upstream
- Continuous biomanufacturing - significant support for this in the small molecule space, what
This session was originally broadcast as part of the CPhI Webinar Series.
